Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2021 Feb 4;14(2):e236784. doi: 10.1136/bcr-2020-236784

Patent foramen ovale presenting with platypnoea-orthodeoxia syndrome and stroke after multi-organ resection

Khaled Elenizi 1,2,, Rasha Alharthi 2
PMCID: PMC7868231  PMID: 33542004

Abstract

Platypnoea-orthodeoxia syndrome (POS) is defined by oxygen desaturation and dyspnoea in upright position that improves by lying down. It results from a right to left shunt at the intracardiac or intrapulmonary level. A 53-year-old ovarian cancer patient presented with POS that was refractory to oxygen therapy. The symptoms began after an extensive abdominal and pelvic surgery as treatment of her cancer with a complex hospital course. A patent foramen ovale was found with the use of transoesophageal echocardiography. A percutaneous closure was done with positive outcome and dyspnoea disappearance. In this case with its challenging clinical setting, we present a unique clinical scenario of an immediate postoperative POS syndrome. We address the different therapeutic modalities and the need for a multidisciplinary medical approach.

Keywords: interventional cardiology, venous thromboembolism, stroke, gynecological cancer

Background

Platypnoea refers to a worsening of dyspnoea that occurs in the upright position and improves with recumbency and orthodeoxia refers to arterial oxygen tension drop by more than 5% or 4 mm Hg in the upright position.1 This could be attributed to intracardiac shunts related to congenital anatomical defects such as patent foramen ovale (PFO), atrial septal defect (ASD) or atrial septal aneurysm with septal fenestrations, with or without elevated right–left gradient. These heart defects are usually accompanied by thoracic or abdominal structural abnormalities in patients presenting with platypnoea-orthodeoxia syndrome (POS).2 POS could also be caused by pulmonary pathologies where there is ventilation/perfusion mismatch or pulmonary arteriovenous shunting.3

POS is considered a rare condition and its true prevalence in the population is not known.4 Clinically, silent PFO is a term described in the literature for uncomplicated PFO. In a minority of cases, the structural defect is discovered after cerebral ischaemic events.5

We present an unusual mechanism of POS mediated by PFO and presented immediately after extensive surgical operation where many abdominal and pelvic organs were removed.

Case presentation

A 53-year-old woman known to have operated ovarian cancer with right salpingo-ovariectomy and adjuvant chemotherapy 1 year ago, history of deep vein thrombosis (DVT) on long-term anticoagulation and iron deficiency anaemia. She was hospitalised for a scheduled laparotomy for the treatment of her cancer where she underwent extensive abdominal and pelvic organ resections that included peritonectomy, splenectomy, hysterectomy, left annexectomy, appendectomy, colectomy, infracolic omentectomy and diaphragm scraping. In the immediate postoperative phase, she presented with abrupt aphasia. On physical examination, blood pressure was 100/60 mm Hg, heart rate 108 bpm, cardiopulmonary auscultation within normal limits, no heart failure signs, aphasic patient, oxygen saturation 98% on 12 L oxygen mask on lying position. ECG found normal sinus tachycardia with no conduction or ischaemic changes. Sodium 137 mmol/L, potassium 3.8 mmol/L, creatinine 46 µmol/L, glomerular filtration rate 109 mL/min and haemoglobin 107 g/L.

Investigations

Brain CT found left middle cerebral artery territory stroke (figure 1). The work up showed PFO on transoesophageal echocardiography (figure 2), while there were no relevant findings with transthoracic echocardiography (TTE).

Figure 1.

Figure 1

CT Brain. Arrow indicates left middle cerebral artery territory stroke.

Figure 2.

Figure 2

Transoesophageal echocardiography showing patent foramen ovale (PFO), right atrium (RA), left atrium (LA), superior vena cava (SVC) and inferior vena cava (IVC).

DVT was found on Doppler ultrasound of lower limbs for which an inferior vena cava filter was implanted due to embolisation of DVT despite therapeutic anticoagulation (figure 3). The hospital stay was characterised by a refractory hypoxia in the setting or standing position which did not respond to optiflow or non-invasive mechanical ventilation, and it disappears on lying position. The patient was diagnosed with POS syndrome. She was then transferred to our cardiology department. Afterwards, heart catheterisation revealed normal right atrial pressure (mean: 6 mm Hg), normal right ventricular pressure (23/8 mm Hg), normal mean pulmonary capillary wedge pressure (10 mm Hg) and left atrial pressure (5 mm Hg). Cardiac output was 6.3 L/min and cardiac index was 3.4 L/min by estimated Fick measurement. Oximetry showed no significant increase in oxygen saturation in right-heart chambers.

Figure 3.

Figure 3

Flouroscopy. Arrow indicates inferior vena cava filter.

Differential diagnosis

High index of suspicion is required to bring it up to deferential diagnosis. The evaluation needs to correlate between dyspnoea and upright posture. Patients can present with POS without underlying cardiac causes. However, similar right-to-left communication can be found in the form of pulmonary arteriovenous malformation or severe ventilation perfusion mismatching.6 This association is also observed in cases of chronic liver disease in the presence of hepatopulmonary syndrome where worsening of oxygen desaturation is observed on standing position.7 In our case, the aetiology of POS was a right-to-left shunt at the cardiac level with no associated extra-cardiac causes.

Treatment

After multidisciplinary team discussion, percutaneous foramen ovale closure was decided to be the strategy of choice for her refractory hypoxia with no other underlying aetiology and to prevent stroke recurrence. The evidence on the effects of PFO closure for the treatment hypoxia is limited to case reports; however, it is promising. Hypoxia was found to improve immediately following PFO closure.8

Our patient was transferred to the catheterisation laboratory where foramen ovale closure was performed using Amplatzer septal occluder (size: 35 mm) (figure 4). The procedure was under general anaesthesia and was guided by transoesophageal echocardiography (TOE) (figure 5). In postprocedural period, TTE showed interatrial prosthesis located in place with no residual shunt along with small pericardial effusion (figure 6).

Figure 4.

Figure 4

Flouroscopy. Arrow indicates Amplatzer 35-mm septal occluder device implantation.

Figure 5.

Figure 5

Percutaneous closure procedure guided by transoesophageal echocardiography, right atrium (RA) and left atrium (LA). Arrow indicates implated septal occluder device.

Figure 6.

Figure 6

Transthoracique echocardiography subcostal view, arrow indiates septal occluder device in position.

Outcome and follow-up

The hypoxia subsided postoperatively and subsequent 3 months follow-up revealed positive outcomes with no hypoxia episodes.

Discussion

Platypnoea orthopnoea syndrome related hypoxia occurs in upright and setting positions and resolves when lying down. As described in our case, it does not respond to oxygen therapy.9 The underlying pathophysiology could be related to cardiac causes represented by intracardiac shunts, for example, PFO, ASD and ASD with fenestrations6 10 or to pulmonary causes represented by pulmonary parenchymal ventilation/perfusion mismatch, and pulmonary arteriovenous shunts.3

PFO is a congenital heart defect that present in 25% of autopsies11 and a minority of patients with this heart defect present with stroke; however, 40% of patients with cryptogenic stroke found to have PFO suggesting its involvement by paradoxical embolism rather than being an incidental finding.12 13 While PFO patients may present with stroke, it is more less frequent that they present with POS with an incidence rate of 2%.8

In most cases of POS caused by heart defects, an additional pathology or a thoracoabdominal anatomical abnormality coexist leading to right-to-left shunt even in the absence of persistent high right-heart pressures. Such pathological conditions include aortic aneurysm, pericardial effusion, pneumonectomy, paralysis of the right hemidiaphragm, kyphoscoliosis and obstructive or restrictive pulmonary diseases.14 15 The presence of PFO only without an associated pathology mostly would not present with positional hypoxia due to the fact that the left atrial pressure is higher than the right atrial pressure preventing right-to-left shunt.10 In fact, the presence of an associated pathology leads to interatrial septal displacement which found to be a critical factor in the development of POS. The occurrence of septal displacement leads to a change in the atrial position that puts the atrial defect directly at the level of blood flow entrance from the inferior vena cava. This displacement becomes more marked in the upright position, which explains why the oxygen desaturation is related to orthostatism.16 17

The first event in our case was a stroke that necessitated inferior vena cava filter placement due to anticoagulation contraindication and the high risk of venous thromboembolism in postoperative period.18 Assuming that thrombi crossed the PFO, this means there is a right-to-left shunt consolidating the diagnosis of POS. Many precipitating factors in patients with POS and PFO were described in the literature as mentioned above; however, post extensive abdominal organs resection have not been reported previously. Nevertheless, the most probable theory in our case is that resection of several abdominopelvic organs has led to a change in volume distribution with less organs accommodating blood and more volume returning to right-heart chambers with an associated septal displacement favouring right-to-left shunt even in the absence of persistent high right-heart pressures.

The use of relevant diagnostic tools confirms the presence of PFO. PFO percutaneous closure has proven to be a safe and a successful treatment for patients with POS, with rapid symptom relief and low complication rates.19 Our patient showed immediate positive outcome with dyspnoea disappearance in postprocedural period. Three-month follow-up showed neither recurrence of dyspnoea nor cerebrovascular events.

Conclusion

A previously silent PFO presented with stroke and POS after extensive abdominal organs resection in a 53-year-old cancer patient. This was managed with percutaneous device closure with positive outcome in 3-month follow-up.

Learning points.

  • Hight index of suspicion is essential to reach rare diagnoses.

  • Multidisciplinary medical approach is a key for good clinical outcomes.

  • Medical interventions could be the triggering event that uncover undiagnosed clinical conditions.

Footnotes

Contributors: RA have contributed in planning, conduct, reporting, acquisition of data conception and design and interpretation of data. KE have contributed in planning, conduct, reporting, acquisition of data conception and design and interpretation of data.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Competing interests: None declared.

Patient consent for publication: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Henkin S, Negrotto S, Pollak PM, et al. Platypnea-orthodeoxia syndrome: diagnostic challenge and the importance of heightened clinical suspicion. Tex Heart Inst J 2015;42:498–501. 10.14503/THIJ-14-4596 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.De Vecchis R, Baldi C, Ariano C. Platypnea–orthodeoxia syndrome: multiple pathophysiological interpretations of a clinical picture primarily consisting of orthostatic dyspnea. J Clin Med 2016;5:85. 10.3390/jcm5100085 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 3.Takhar R, Biswas R, Arora A, et al. Platypnoea-orthodeoxia syndrome: novel cause for a known condition. BMJ Case Rep 2014;2014. 10.1136/bcr-2013-201284. [Epub ahead of print: 07 Mar 2014]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Rodrigues P, Palma P, Sousa-Pereira L. Platypnea-orthodeoxia syndrome in review: defining a new disease? Cardiology 2012;123:15–23. 10.1159/000339872 [DOI] [PubMed] [Google Scholar]
  • 5.De Vecchis R, Baldi C, Cantatrione S. Transcatheter closure of PFO as secondary prevention of cryptogenic stroke. Herz 2017;42:45–50. 10.1007/s00059-016-4432-6 [DOI] [PubMed] [Google Scholar]
  • 6.Tenholder MF, Russell MD, Knight E, et al. Orthodeoxia: a new finding in interstitial fibrosis. Am Rev Respir Dis 1987;136:170–3. 10.1164/ajrccm/136.1.170 [DOI] [PubMed] [Google Scholar]
  • 7.Nagata T, Matsumoto A, Uehara Y, et al. Oxygenation abnormalities in normoxemic patients with mild liver cirrhosis. Intern Med 2002;41:435–40. 10.2169/internalmedicine.41.435 [DOI] [PubMed] [Google Scholar]
  • 8.Blanche C, Noble S, Roffi M, et al. Platypnea-orthodeoxia syndrome in the elderly treated by percutaneous patent foramen ovale closure: a case series and literature review. Eur J Intern Med 2013;24:813–7. 10.1016/j.ejim.2013.08.698 [DOI] [PubMed] [Google Scholar]
  • 9.Godart F, Rey C, Prat A, et al. Atrial right-to-left shunting causing severe hypoxaemia despite normal right-sided pressures. Report of 11 consecutive cases corrected by percutaneous closure. Eur Heart J 2000;21:483–9. 10.1053/euhj.1999.1944 [DOI] [PubMed] [Google Scholar]
  • 10.Hirai N, Fukunaga T, Kawano H, et al. Platypnea - orthodeoxia syndrome with atrial septal defect. Circ J 2003;67:172–5. 10.1253/circj.67.172 [DOI] [PubMed] [Google Scholar]
  • 11.Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17–20. 10.1016/S0025-6196(12)60336-X [DOI] [PubMed] [Google Scholar]
  • 12.Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med Overseas Ed 1988;318:1148–52. 10.1056/NEJM198805053181802 [DOI] [PubMed] [Google Scholar]
  • 13.Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke. Stroke 2009;40:2349–55. 10.1161/STROKEAHA.109.547828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.De Vecchis R, Baldi C, Ariano C. Platypnea-orthodeoxia syndrome: multiple pathophysiological interpretations of a clinical picture primarily consisting of orthostatic dyspnea. J Clin Med 2016;5:85. 10.3390/jcm5100085 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 15.Cheng TO Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management. Catheter Cardiovasc Interv 1999;47:64–6. [DOI] [PubMed] [Google Scholar]
  • 16.Akin E, Krüger U, Braun P, et al. The platypnea-orthodeoxia syndrome. Eur Rev Med Pharmacol Sci 2014;18:2599–604. [PubMed] [Google Scholar]
  • 17.Bovelli D, Khoury G, Consalvi G, et al. [An unusual type of dyspnea]. G Ital Cardiol 2008;9:367–71. [PubMed] [Google Scholar]
  • 18.DeYoung E, Minocha J. Inferior vena cava filters: guidelines, best practice, and expanding indications. Semin Intervent Radiol 2016;33:065–70. 10.1055/s-0036-1581088 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Guérin P, Lambert V, Godart F, et al. Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: results of a multicentric French registry. Cardiovasc Intervent Radiol 2005;28:164–8. 10.1007/s00270-004-0035-3 [DOI] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES